Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.32B |
| 2 |
AstraZeneca
AZN
|
+$733M |
| 3 |
Microsoft
MSFT
|
+$728M |
| 4 |
Cadence Design Systems
CDNS
|
+$720M |
| 5 |
Moody's
MCO
|
+$359M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$1.43B |
| 2 |
Estee Lauder
EL
|
+$872M |
| 3 |
Eli Lilly
LLY
|
+$626M |
| 4 |
Netflix
NFLX
|
+$521M |
| 5 |
UnitedHealth
UNH
|
+$466M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.62% |
| 3 | Healthcare | 16.16% |
| 4 | Financials | 9.12% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.81T
| $7.42B | 6.81% |
25,738,214
+2,854,370
| +12% | +$728M |
|
2
Apple
AAPL
$4.67T
| $6.88B | 6.31% |
41,711,097
-2,562,691
| -6% | -$378M |
|
3
NVIDIA
NVDA
$5.25T
| $6.29B | 5.77% |
226,359,910
-6,633,000
| -3% | -$144M |
|
4
Amazon
AMZN
$2.87T
| $4.48B | 4.11% |
43,418,274
-699,406
| -2% | -$67.6M |
|
5
Tesla
TSLA
$1.38T
| $4.2B | 3.85% |
20,245,122
+1,403,952
| +7% | +$245M |
|
|
6
Eli Lilly
LLY
$1.05T
| $2.94B | 2.7% |
8,574,164
-1,854,917
| -18% | -$626M |
|
7
Mercado Libre
MELI
$99.7B
| $2.88B | 2.64% |
2,183,943
-13,478
| -0.6% | -$15.3M |
|
8
Visa
V
$712B
| $2.84B | 2.6% |
12,587,919
-649,565
| -5% | -$145M |
|
9
Mastercard
MA
$521B
| $2.83B | 2.6% |
7,789,985
-38,877
| -0.5% | -$14.1M |
|
10
Alphabet (Google) Class A
GOOGL
$4.24T
| $2.22B | 2.04% |
21,439,734
-3,852,071
| -15% | -$370M |
|
11
Costco
COST
$419B
| $2.13B | 1.96% |
4,295,463
+12,855
| +0.3% | +$6.3M |
|
|
12
Alphabet (Google) Class C
GOOG
$4.19T
| $2.11B | 1.93% |
20,263,884
-3,543,080
| -15% | -$342M |
|
|
NVO
13
Novo Nordisk
NVO
$202B
| $1.96B | 1.8% |
24,682,922
+1,773,358
| +8% | +$126M |
|
|
14
UnitedHealth
UNH
$353B
| $1.76B | 1.61% |
3,723,495
-964,652
| -21% | -$466M |
|
15
Broadcom
AVGO
$1.75T
| $1.7B | 1.56% |
26,447,560
+3,449,160
| +15% | +$208M |
|
16
lululemon athletica
LULU
$13.7B
| $1.61B | 1.48% |
4,427,819
+101,039
| +2% | +$31.7M |
|
17
Adobe
ADBE
$116B
| $1.6B | 1.47% |
4,148,706
-92,439
| -2% | -$32.9M |
|
|
18
Advanced Micro Devices
AMD
$760B
| $1.59B | 1.46% |
+16,272,765
| New | +$1.32B |
|
19
Uber
UBER
$161B
| $1.46B | 1.34% |
46,082,453
-918,528
| -2% | -$29.1M |
|
20
Vertex Pharmaceuticals
VRTX
$137B
| $1.44B | 1.32% |
4,579,801
-535,739
| -10% | -$161M |
|
21
Salesforce
CRM
$211B
| $1.44B | 1.32% |
7,190,284
-401,449
| -5% | -$67.8M |
|
22
Danaher
DHR
$152B
| $1.37B | 1.25% |
6,117,913
-254,372
| -4% | -$57.9M |
|
|
23
Netflix
NFLX
$340B
| $1.36B | 1.24% |
39,254,850
-15,739,060
| -29% | -$521M |
|
24
SLB Ltd
SLB
$85.1B
| $1.31B | 1.2% |
26,592,609
-54,662
| -0.2% | -$2.9M |
|
25
T-Mobile US
TMUS
$195B
| $1.19B | 1.09% |
8,218,565
+1,537,169
| +23% | +$223M |
|
Similar funds
Jennison Associates's Q1 2023 Portfolio in Review
As of Q1 2023, Jennison Associates held 644 positions worth $109B, up 10% from $98.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jennison Associates withdrew a net $3.94B in Q1 2023, closing 63 positions and reducing 280 holdings. Its most notable exit was Alcon, an estimated $1.43B position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Advanced Micro Devices worth $1.59B.
- Jennison Associates's largest Q1 2023 buy was Advanced Micro Devices: 16,272,765 shares worth $1.59B.
- Jennison Associates added most to AstraZeneca in Q1 2023, an estimated $733M increase.
- Jennison Associates's biggest Q1 2023 reduction was Estee Lauder, cutting an estimated $872M.
- Jennison Associates fully exited Alcon in Q1 2023, selling an estimated $1.43B.
- Jennison Associates's ten largest holdings make up 39% of its $109B portfolio in Q1 2023.
- Jennison Associates opened 73 new positions and closed 63 in Q1 2023.
- Jennison Associates's portfolio value rose 10% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q1 2023, filed 26 Apr 2023.